Welcome to Hubei Haosun Pharmaceutical Co.,Ltd.
Home| Order | Contact us
News

Pass EDQM audit

Audit time: on July 11 to 13, 2016

After three days of EDQM audit, our five API products Docetaxel anhydrous, Amisulpride, Granisetron HCl, Flumazenil and Oxaliplatin approved by EDQM.